Nick Talken

Nick Talken is the Co-Founder and CEO of Albert Invent, an Oakland-based AI platform that is transforming how chemists and materials scientists do research and development. A chemical engineer by training who learned to code, Talken spent years inside Henkel's global R&D organization before spinning out Albert Invent in 2022 with a team of co-founders who built the product from within. The company's platform - used by over 3,000 scientists across 142+ labs in 30+ countries at companies like Kenvue, Henkel, and Chemours - has raised over $52 million from top-tier investors including Coatue, Index Ventures, TCV, and J.P. Morgan Private Capital.